瑞马唑仑神经保护机制及临床应用研究进展OA
Advances in neuroprotective mechanisms and clinical applications of remimazolam
在临床麻醉与重症监护治疗过程中,神经系统损伤较为常见,传统镇静药物往往伴随着诸多不良反应,因此迫切需要安全且有效的神经保护药物.瑞马唑仑作为一种新型超短效苯二氮䓬类药物,凭借其安全性高且不依赖肝肾功能的独特优势,已在临床广泛应用.近期研究发现,该药物在发挥镇静作用外,还表现出潜在的神经保护功能.本文系统综述瑞马唑仑在神经保护作用机制方面的研究成果,明确瑞马唑仑作用方式及分子机制,以期为临床合理用药及后续研究提供理论参考,促进治疗水平提升并改善患者预后.
Neurological injury is relatively common during clinical anesthesia and intensive care treatment.Traditional sedative drugs often come with numerous adverse reactions,creating an urgent need for safe and effective neuroprotective medications.Remimazolam,as a novel ultra-short-acting benzodiazepine,has been widely used in clinical practice due to its high safety profile and unique advantage of not relying on hepatic or renal function.Recent studies have revealed that beyond its sedative effects,this drug exhibits potential neuroprotective functions.This systematic review summarizes research findings on the neuroprotective mechanisms of remimazolam,clarifying its mode of action and molecular mechanisms.It aims to provide theoretical guidance for rational clinical use and future research,thereby advancing treatment standards and improving patient outcomes.
王奇伟;白栓成
内蒙古医科大学包头临床医学院,内蒙古 包头 014040内蒙古医科大学包头临床医学院,内蒙古 包头 014040
瑞马唑仑神经保护麻醉镇静
remimazolamneuroprotectionanesthesiasedation
《麻醉安全与质控》 2026 (2)
172-177,6
公立医院科研联合基金科技项目(2023GLLH0236)
评论